vs
宏盟集团（OMC）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是宏盟集团的1.1倍（$7.2B vs $6.2B），Stryker Corporation净利率更高（11.8% vs 6.7%，领先5.1%），Stryker Corporation同比增速更快（11.4% vs -16.2%），过去两年宏盟集团的营收复合增速更高（27.3% vs 16.9%）
宏盟集团（Omnicom Group）是总部位于美国纽约的全球性传媒、营销及企业传播控股集团，旗下拥有多家行业领先的广告、公关、媒介服务子品牌，为全球各行业客户提供专业整合营销传播解决方案，在全球营销服务领域占据领先市场地位。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
OMC vs SYK — 直观对比
营收规模更大
SYK
是对方的1.1倍
$6.2B
营收增速更快
SYK
高出27.6%
-16.2%
净利率更高
SYK
高出5.1%
6.7%
两年增速更快
OMC
近两年复合增速
16.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2B | $7.2B |
| 净利润 | $418.7M | $849.0M |
| 毛利率 | — | 64.5% |
| 营业利润率 | 10.4% | 25.2% |
| 净利率 | 6.7% | 11.8% |
| 营收同比 | -16.2% | 11.4% |
| 净利润同比 | 38.0% | 55.5% |
| 每股收益（稀释后） | $1.35 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OMCSYK
| Q1 26 | $6.2B | — | ||
| Q4 25 | $5.5B | $7.2B | ||
| Q3 25 | $4.0B | $6.1B | ||
| Q2 25 | $4.0B | $6.0B | ||
| Q1 25 | $3.7B | $5.9B | ||
| Q4 24 | $4.3B | $6.4B | ||
| Q3 24 | $3.9B | $5.5B | ||
| Q2 24 | $3.9B | $5.4B |
净利润OMCSYK
| Q1 26 | $418.7M | — | ||
| Q4 25 | $-941.1M | $849.0M | ||
| Q3 25 | $341.3M | $859.0M | ||
| Q2 25 | $257.6M | $884.0M | ||
| Q1 25 | $287.7M | $654.0M | ||
| Q4 24 | $448.0M | $546.0M | ||
| Q3 24 | $385.9M | $834.0M | ||
| Q2 24 | $328.1M | $825.0M |
毛利率OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | -10.6% | 64.5% | ||
| Q3 25 | 18.7% | 63.6% | ||
| Q2 25 | 16.6% | 63.8% | ||
| Q1 25 | 17.1% | 63.8% | ||
| Q4 24 | 19.8% | 64.9% | ||
| Q3 24 | 19.6% | 64.0% | ||
| Q2 24 | 17.7% | 63.0% |
营业利润率OMCSYK
| Q1 26 | 10.4% | — | ||
| Q4 25 | -17.7% | 25.2% | ||
| Q3 25 | 13.1% | 18.7% | ||
| Q2 25 | 10.9% | 18.5% | ||
| Q1 25 | 12.3% | 14.3% | ||
| Q4 24 | 15.9% | 9.0% | ||
| Q3 24 | 15.5% | 19.7% | ||
| Q2 24 | 13.2% | 19.4% |
净利率OMCSYK
| Q1 26 | 6.7% | — | ||
| Q4 25 | -17.0% | 11.8% | ||
| Q3 25 | 8.5% | 14.2% | ||
| Q2 25 | 6.4% | 14.7% | ||
| Q1 25 | 7.8% | 11.1% | ||
| Q4 24 | 10.4% | 8.5% | ||
| Q3 24 | 9.9% | 15.2% | ||
| Q2 24 | 8.5% | 15.2% |
每股收益（稀释后）OMCSYK
| Q1 26 | $1.35 | — | ||
| Q4 25 | $-4.78 | $2.20 | ||
| Q3 25 | $1.75 | $2.22 | ||
| Q2 25 | $1.31 | $2.29 | ||
| Q1 25 | $1.45 | $1.69 | ||
| Q4 24 | $2.27 | $1.41 | ||
| Q3 24 | $1.95 | $2.16 | ||
| Q2 24 | $1.65 | $2.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $22.4B |
| 总资产 | — | $47.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $1.9B |
总债务OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | $9.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $6.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | $12.0B | $22.4B | ||
| Q3 25 | $4.6B | $21.8B | ||
| Q2 25 | $4.5B | $21.2B | ||
| Q1 25 | $4.4B | $20.9B | ||
| Q4 24 | $4.2B | $20.6B | ||
| Q3 24 | $4.0B | $20.1B | ||
| Q2 24 | $3.6B | $19.8B |
总资产OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | $54.4B | $47.8B | ||
| Q3 25 | $28.8B | $47.1B | ||
| Q2 25 | $28.8B | $46.3B | ||
| Q1 25 | $28.1B | $46.0B | ||
| Q4 24 | $29.6B | $43.0B | ||
| Q3 24 | $28.8B | $43.8B | ||
| Q2 24 | $27.3B | $39.1B |
负债/权益比OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | 0.77× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $2.1B |
| 自由现金流经营现金流 - 资本支出 | — | $1.9B |
| 自由现金流率自由现金流/营收 | — | 26.1% |
| 资本支出强度资本支出/营收 | — | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | — | $4.3B |
8季度趋势，按日历期对齐
经营现金流OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $477.5M | $1.5B | ||
| Q2 25 | $210.1M | $1.1B | ||
| Q1 25 | $-786.8M | $250.0M | ||
| Q4 24 | $1.9B | $1.9B | ||
| Q3 24 | $568.7M | $1.5B | ||
| Q2 24 | $-141.7M | $633.0M |
自由现金流OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $1.9B | ||
| Q3 25 | $438.4M | $1.4B | ||
| Q2 25 | $168.0M | $928.0M | ||
| Q1 25 | $-816.3M | $127.0M | ||
| Q4 24 | $1.9B | $1.7B | ||
| Q3 24 | $537.4M | $1.3B | ||
| Q2 24 | $-180.9M | $481.0M |
自由现金流率OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | 54.2% | 26.1% | ||
| Q3 25 | 10.9% | 22.3% | ||
| Q2 25 | 4.2% | 15.4% | ||
| Q1 25 | -22.1% | 2.2% | ||
| Q4 24 | 43.5% | 25.9% | ||
| Q3 24 | 13.8% | 23.7% | ||
| Q2 24 | -4.7% | 8.9% |
资本支出强度OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 3.7% | ||
| Q3 25 | 1.0% | 3.1% | ||
| Q2 25 | 1.0% | 3.0% | ||
| Q1 25 | 0.8% | 2.1% | ||
| Q4 24 | 1.1% | 4.1% | ||
| Q3 24 | 0.8% | 3.1% | ||
| Q2 24 | 1.0% | 2.8% |
现金转化率OMCSYK
| Q1 26 | — | — | ||
| Q4 25 | — | 2.52× | ||
| Q3 25 | 1.40× | 1.79× | ||
| Q2 25 | 0.82× | 1.26× | ||
| Q1 25 | -2.73× | 0.38× | ||
| Q4 24 | 4.30× | 3.54× | ||
| Q3 24 | 1.47× | 1.77× | ||
| Q2 24 | -0.43× | 0.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OMC
暂无分部数据
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
